CD44 and head and neck squamous cell carcinoma: Byun et al. [133] demonstrated that CD44+ HNSCC cells were relatively resistant to cisplatin and radiation, and knockdown of hypoxia-inducible factor (HIF-1) or Notch1 enhanced the chemosensitivity to cisplatin or radiation treatment as compared to the control.